Font Size

Understanding Psoriasis Medications (cont.)

Other Systemic Agents for Psoriasis

Antimetabolites, Immunosuppressives, and Biologic Response Modifiers

These agents are potent drugs given by mouth or injection. They block inflammation and have effects on the immune system. The effect on skin is probably secondary to the effect on white blood cells.

Adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), methotrexate (Rheumatrex), cyclosporine (Sandimmune, Neoral), and apremilast (Otezla) are in this group of systemic drugs. They may be prescribed for moderate to severe psoriasis.

How these drugs work: These medications can block inflammation. They are used to treat people with severe disabling psoriasis who have not responded to or tolerated other treatments.

  • The Biologics: Adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), ustekinumab (Stelara), secukinumab (Cosentyx), and ixekizumab (Taltz) are proteins, also called "biologics," that are produced by microorganisms and work on the immune system by blocking certain specific chemical messengers of the inflammatory pathway. For example, tumor necrosis factor (TNF) is involved in inflammation and is blocked by three of these medications. They all are expensive.
    • Who should not use biologics: Individuals with an allergy to these medications and those with a serious infection should not use these drugs.
    • Use:
      • Adalimumab is self-administered as an injection every two weeks.
      • Etanercept is given as an injection two times per week. The drug can be injected at home. Rotate the site of injection (thigh, upper arm, abdomen). Do not inject into bruised, hard, or tender skin.
      • Infliximab must be administered in the doctor's office. It is an intravenous (IV, given into the vein) infusion that is administered slowly over two hours. Initially, three doses are administered within a six-week period, and then the drug is administered every eight weeks for maintenance.
      • Ustekinumab, secukinumab, and ixekizumab are administered by injection at longer intervals after a short induction phase.
    • Drug or food interactions: The safety and efficacy of these medications in patients receiving other immunosuppressive drugs have not been evaluated. Patients receiving these medications may receive concurrent vaccinations, except for live vaccines, such as the MMR and yellow fever vaccines.
    • Adverse effects: Serious infections may develop and the therapy should be discontinued if they occur. Possible adverse effects include injection-site pain, redness and swelling at injection site, and headaches. Rarely, lupus-like symptoms, lymphoma, reactivation of tuberculosis, and heart failure have been reported (treatment is stopped if symptoms develop).
  • Methotrexate (Rheumatrex): This drug is used to treat plaque psoriasis and psoriatic arthritis. However, it is sometimes not effective.
    • Who should not use methotrexate: Women who are planning to get pregnant or who are pregnant should not take this drug. Men must not take this drug if there is a possibility of getting their partners pregnant because it can go into the sperm. Additionally, people with the following conditions should not use methotrexate:
      • Methotrexate allergy
      • Alcoholism
      • Liver or kidney problems
      • Immune deficiency syndromes
      • Low blood cell levels
    • Use: Methotrexate is taken by mouth (tablet) or as an injection once per week.
    • Drug or food interactions: Tell the doctor if any nonsteroidal anti-inflammatory drugs (Motrin, Advil, Aleve, aspirin) are being taken because these may act with methotrexate and cause adverse symptoms.
    • Adverse effects: The doctor will order blood tests to check blood cell count and liver and kidney function on a regular basis. Methotrexate may cause toxic effects on the blood, kidneys, liver, gastrointestinal tract, lungs, and nervous system. A liver biopsy may be needed to check the health of the liver, especially after prolonged use.
  • Cyclosporine (Sandimmune, Neoral)
  • Apremilast (Otezla)
    • This drug works by inhibiting an enzyme that plays a role in the inflammatory process.
    • Who should not use apremilast: Anyone with a known sensitivity to the drug
    • Use: This is a newly developed oral drug for the treatment of psoriasis and psoriatic arthritis. Its efficacy is touted as being similar to the biologic response modifiers. Major side effects seem to be gastrointestinal so that it is recommended to start with a low dose and gradually increase it to the full therapeutic amount over about a week to avoid intolerable GI symptoms. No special laboratory tests for monitoring are required.
    • Adverse events: Major adverse events are gastrointestinal upset and subsequent weight loss.
Medically Reviewed by a Doctor on 7/14/2016

Must Read Articles Related to Understanding Psoriasis Medications

Nail Psoriasis
Nail Psoriasis Psoriasis is a common condition. learn more >>

Patient Comments & Reviews

The eMedicineHealth doctors ask about Psoriasis Medications:

Psoriasis Medications - Treatment

What medication has worked best for your psoriasis?

Psoriasis Medications - Topical

What topical medication has helped to alleviate your psoriasis symptoms and signs?

Psoriasis Medications - Oral

What oral medications have helped your psoriasis symptoms and signs?

Read What Your Physician is Reading on Medscape

Psoriasis »

Psoriasis is a chronic, noncontagious, multisystem, inflammatory disorder.

Read More on Medscape Reference »

Medical Dictionary